Natural course of incidentally found nonfunctioning pituitary adenoma, with special reference to pituitary apoplexy during follow-up examination

Restricted access

Object

The increase in the incidental detection of asymptomatic pituitary adenomas, known as “pituitary inciden-talomas,” led the authors to conduct a survey of the natural course of these lesions.

Methods

Forty-two patients with clinically nonfunctioning pituitary adenomas who had manifested no neurological or endocrinological disorders were monitored with magnetic resonance imaging studies. The follow-up period ranged from 10.8 to 168.2 months (mean ± standard deviation, 61.9 ± 38.2 months). The mean initial tumor size was 18.3 ± 7 mm.

In 21 patients, the tumor increased by at least 10% of its measured size on detection. This increase was first detected between 8.4 and 58.8 months (mean 31.8 ± 17.6 months) after diagnosis. There was no correlation between the original tumor size, patient age, or the presence of intratumoral cysts and tumor growth. Symptoms were noted in 10 patients during follow up; in four, extensive tumor necrosis accompanied hemorrhage, leading to severe headache, acute ophthalmological symptoms, and panhypopituitarism, which was indicative of pituitary apoplexy. Transsphenoidal surgery was performed in 12 patients with enlarged tumors, including three with apoplexy. With the exception of one apoplectic patient, visual function was recovered in all who underwent surgery. All apoplectic patients continue to manifest hypopituitarism.

Conclusions

In the course of 4 years, the size of the incidentalomas increased in 40% of 42 patients and became symptomatic in 20%. During the 5-year follow up, pituitary apoplexy developed in 9.5%. These findings may justify early intervention, especially in young individuals with incidentally found macroadenoma.

Abbreviations used in this paper:LHRH = luteinizing hormone–releasing hormone; MR = magnetic resonance; TSS = transsphenoidal surgery.

Article Information

Address reprint requests to: Kazunori Arita, M.D., Department of Neurosurgery, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1, Sakuragoaka, Kagoshima, 890-8520, Japan. email: karita@m2.kagoshima-u.ac.jp.

© AANS, except where prohibited by US copyright law.

Headings

Figures

  • View in gallery

    Images obtained in a 46-year-old man with chronic headache. Coronal (a) and sagittal (b) MR images demonstrating an asymptomatic pituitary adenoma with a height of 17 mm. Perimetry maps showing normal visual fields in both the left (c) and right (d) eyes. Follow-up MR images obtained 28 months postdiagnosis showed an increase in tumor height to 22 mm. Coronal (e) and sagittal (f) MR images obtained 71 months postdiagnosis revealing a tumor height of 25 mm. Perimetry maps demonstrating the appearance of visual field defects in the left (g) and right (h) eyes.

  • View in gallery

    Kaplan–Meier survival curve demonstrating tumor enlargement–free survival in 42 patients with incidentally found pituitary adenoma.

  • View in gallery

    Graph showing the percentage changes in the height of 21 enlarged adenomas. The tumor height measured at the latest follow-up examination was 110 to 180% of the height measured on initial diagnosis.

  • View in gallery

    Kaplan–Meier survival curve demonstrating symptom-free survival in patients with incidentally found pituitary adenomas. The solid line represents all 42 patients. Open circles indicate cases with pituitary apoplexy. The thin dotted line indicates 28 patients with adenomas whose initial size was larger than 15 mm, whereas the bold dotted and dashed line represents 14 patients with adenomas whose initial size was 15 mm or smaller. The risk for symptomatic tumor enlargement was significantly greater with tumors whose height on detection exceeded 15 mm compared with those whose height was less than 15 mm (Cox–Mantel test, p = 0.007).

  • View in gallery

    Coronal (a) and sagittal (b) MR images obtained in a 52-year old man, revealing a pituitary adenoma with slight suprasellar extension. Coronal (c) and sagittal (d) follow-up MR images obtained 16 months postdiagnosis and 2 days after his apoplectic attack, showing hemorrhagic infarction in the tumor and parasellar dural enhancement. These findings are compatible with pituitary apoplexy. This case was previously reported in Arita, et al., 2001.

  • View in gallery

    Coronal (a) and sagittal (b) MR images obtained in a 74-year-old man, demonstrating a pituitary adenoma measuring 18 mm in height with slight compression of the chiasm. Follow-up coronal (c) and sagittal (d) MR images were obtained 26 months postdiagnosis, 1 day after injection of an LHRH analog, which elicited severe headache, showing an increase in tumor size and intratumoral hemorrhagic infarction.

  • View in gallery

    Coronal (a) and sagittal (b) MR images obtained in a 60-year-old woman, revealing a pituitary adenoma measuring 20 mm in height without suprasellar extension. Coronal (c) and sagittal (d) MR images obtained 20 months postdiagnosis because of acute deterioration in left-sided eyesight, showing that the tumor size had increased. Note compression of the chiasm and an intratumoral fluid hematoma.

  • View in gallery

    Coronal (a) and sagittal (b) MR images obtained in a 61-year-old man, revealing a pituitary adenoma measuring 18 mm in height. Coronal (c) and sagittal (d) MR images obtained 56 months postdiagnosis and 4 days after an apoplectic attack, showing tumor enlargement, peritumoral dural enhancement, and mucosal thickening of the sphenoid sinus.

References

  • 1

    Arita KKurisu KTominaga AEguchi KIida KUozumi T: Mortality in 154 surgically treated patients with acromegaly—a 10-year follow-up survey. Endocr J 50:1631722003

  • 2

    Arita KKurisu KTominaga ASugiyama KIkawa FYoshioka H: Thickening of sphenoid sinus mucosa during the acute stage of pituitary apoplexy. J Neurosurg 95:8979012001

  • 3

    Aron DCHowlett TA: Pituitary incidentalomas. Endocrinol Metab Clin North Am 29:2052212000

  • 4

    Bills DCMeyer FBLaws ER JrDavis DHEbersold MJScheithauer BW: A retrospective analysis of pituitary apoplexy. Neurosurgery 33:6026091993

  • 5

    Biousse VNewman NJOyesiku NM: Precipitating factors in pituitary apoplexy. J Neurol Neurosurg Psychiat 71:5425452001

  • 6

    Cardoso ERPetersen EW: Pituitary apoplexy: a review. Neurosurgery 14:3633731984

  • 7

    Ciric IRagin ABaumgartner CPierce D: Complications of transsphenoidal surgery: results of a national survey, review of the literature, and personal experience. Neurosurgery 40:2252371997

  • 8

    Donovan LECorenblum B: The natural history of the pituitary incidentaloma. Arch Intern Med 155:1811831995

  • 9

    Feldkamp JSanten RHarms EAulich AModder UScherbaum WA: Incidentally discovered pituitary lesions: high frequency of macroadenomas and hormone-secreting adenomas—results of a prospective study. Clin Endocrinol (Oxf) 51:1091131999

  • 10

    Hall WALuciano MGDoppman JLPatronas NJOldfield EH: Pituitary magnetic resonance imaging in normal human volunteers: occult adenomas in the general population. Ann Intern Med 120:8178201994

  • 11

    Hatayama KAbe TEndo TKobayashi NShimazu MSasaki K: [Pituitary cystic mass with spontaneous disappearance: three cases of equivocal Rathke’s cleft cyst]. No To Shinkei 52:9299332000. (Jpn)

  • 12

    Igarashi TSaeki NYamaura A: Long-term magnetic resonance imaging follow-up of asymptomatic sellar tumors — their natural history and surgical indications. Neurol Med Chir (Tokyo) 39:5925991999

  • 13

    Kaufman BArafah BSelman WR: Advances in neuroradiologic imaging of the pituitary gland: changing concepts. J Lab Clin Med 109:3083191987

  • 14

    Klibanski AZervas NT: Diagnosis and management of hormonesecreting pituitary adenomas. N Engl J Med 324:8228311991

  • 15

    Kovacs KRyan NHorvath ESinger WEzrin C: Pituitary adenomas in old age. J Gerontol 35:16221980

  • 16

    Laws ER JrEbersold MD: Pituitary apoplexy—an endocrine emergency. World J Surg 6:6866881982

  • 17

    Long SAArriaga MNelson RA: Acoustic neuroma volume: MRI-based calculations and clinical implications. Laryngoscope 103:109310961993

  • 18

    Lundin PPedersen F: Volume of pituitary macroadenomas: assessment by MRI. J Comput Assist Tomogr 16:5195281992

  • 19

    The Ministry of Health Labour and Welfare: Abridged Life Tables for 1999. (http://www1.mhlw.go.jp/english/database/lifetb99_8) [Accessed 20 May 2005]

  • 20

    Molitch ME: Clinical review 65. Evaluation and treatment of the patient with a pituitary incidentaloma. J Clin Endocrinol Metab 80:361995

  • 21

    Molitch MERussell EJ: The pituitary “incidentaloma”. Ann Intern Med 112:9259311990

  • 22

    Newton DRDillon WPNorman DNewton THWilson CB: Gd-DTPA-enhanced MR imaging of pituitary adenomas. AJNR Am J Neuroradiol 10:9499541989

  • 23

    Nishizawa SOhta SYokoyama TUemura K: Therapeutic strategy for incidentally found pituitary tumors (“pituitary incidentalomas”). Neurosurgery 43:134413501998

  • 24

    Parent ADBebin JSmith RR: Incidental pituitary adenomas. J Neurosurg 54:2282311981

  • 25

    Reincke MAllolio BSaeger WMenzel JWinkelman W: The ‘incidentaloma’ of the pituitary gland. Is neurosurgery required?. JAMA 263:277227761990

  • 26

    Saeki NSunami YSugaya YYamaura A: MRI findings and clinical manifestations in Rathke’s cleft cyst. Acta Neurochir (Wien) 141:105510611999

  • 27

    Sanno NOyama KTahara STeramoto AKato Y: A survey of pituitary incidentaloma in Japan. Eur J Endocrinol 149:1231272003

  • 28

    Semple PLWebb MKde Villiers JCLaws ER Jr: Pituitary apoplexy. Neurosurgery 56:65732005

  • 29

    Sumida MUozumi TMukada KArita KKurisu KEguchi K: Rathke cleft cysts: correlation of enhanced MR and surgical findings. AJNR Am J Neuroradiol 15:5255321994

  • 30

    Sumida MUozumi TYamanaka MMukada KArita KKurisu K: Displacement of the normal pituitary gland by sellar and juxtasellar tumors: surgical-MRI correlation and use in differential diagnosis. Neuroradiology 36:3723751994

  • 31

    Tanaka YHongo KTada TSakai KKakizawa YKobayashi S: Growth pattern and rate in residual nonfunctioning pituitary adenomas: correlations among tumor volume doubling time, patient age, and MIB-1 index. J Neurosurg 98:3593652003

  • 32

    Teramoto AHirakawa KSanno NOsamura Y: Incidental pituitary lesions in 1,000 unselected autopsy specimens. Radiology 193:1611641994

  • 33

    Yue NCLongstreth WT JrElster ADJungreis CAO’Leary DHPoirier VC: Clinically serious abnormalities found incidentally at MR imaging of the brain: data from the Cardiovascular Health Study. Radiology 202:41461997

TrendMD

Metrics

Metrics

All Time Past Year Past 30 Days
Abstract Views 192 192 35
Full Text Views 187 187 6
PDF Downloads 93 93 4
EPUB Downloads 0 0 0

PubMed

Google Scholar